158 related articles for article (PubMed ID: 31972599)
1. Advances in the treatment of biliary tract cancers.
Uson Junior PLS; Bogenberger J; Borad MJ
Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599
[TBL] [Abstract][Full Text] [Related]
2. Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials.
Chiang NJ; Chen LT; Shan YS; Yeh CN; Chen MH
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33451059
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives.
Filippi R; Lombardi P; Quarà V; Fenocchio E; Aimar G; Milanesio M; Leone F; Aglietta M
Expert Opin Pharmacother; 2019 Dec; 20(17):2121-2137. PubMed ID: 31550186
[No Abstract] [Full Text] [Related]
4. Biliary tract cancers: systemic therapy for advanced disease.
Martinez FJ; Shroff RT
Chin Clin Oncol; 2020 Feb; 9(1):5. PubMed ID: 32008329
[TBL] [Abstract][Full Text] [Related]
5. Continuum of care for advanced biliary tract cancers.
Vienot A; Neuzillet C
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):810-824. PubMed ID: 32586782
[TBL] [Abstract][Full Text] [Related]
6. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
Akhoundova Sanoyan D; McNamara MG; Lamarca A; Valle JW
Curr Opin Oncol; 2020 Jul; 32(4):364-369. PubMed ID: 32541326
[TBL] [Abstract][Full Text] [Related]
8. New developments in systemic therapy for advanced biliary tract cancer.
Morizane C; Ueno M; Ikeda M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Aug; 48(8):703-711. PubMed ID: 29893894
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and network meta-analysis of adjuvant therapy for curatively resected biliary tract cancers.
Kish M; Chan K; Perry K; Ko YJ
Curr Oncol; 2020 Feb; 27(1):e20-e26. PubMed ID: 32218664
[TBL] [Abstract][Full Text] [Related]
10. Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation.
Athauda A; Fong C; Lau DK; Javle M; Abou-Alfa GK; Morizane C; Steward K; Chau I
Cancer Treat Rev; 2020 Jun; 86():101998. PubMed ID: 32203843
[TBL] [Abstract][Full Text] [Related]
11. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
[TBL] [Abstract][Full Text] [Related]
12. The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy.
Demols A; Bucalau AM; Mans L
Curr Opin Oncol; 2022 Jul; 34(4):403-411. PubMed ID: 35837710
[TBL] [Abstract][Full Text] [Related]
13. Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.
Rizzo A; Ricci AD; Tober N; Nigro MC; Mosca M; Palloni A; Abbati F; Frega G; DE Lorenzo S; Tavolari S; Brandi G
Anticancer Res; 2020 Jun; 40(6):3013-3030. PubMed ID: 32487595
[TBL] [Abstract][Full Text] [Related]
14. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
[TBL] [Abstract][Full Text] [Related]
15. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.
Kus T; Aktas G; Kalender ME; Sevinc A; Camci C
J Gastrointest Cancer; 2017 Jun; 48(2):170-175. PubMed ID: 27714651
[TBL] [Abstract][Full Text] [Related]
16. [Biliary tract cancer: on the way to a personalized therapy].
Sinn M; Wege H; Stein A
Dtsch Med Wochenschr; 2020 Apr; 145(7):442-446. PubMed ID: 32236923
[TBL] [Abstract][Full Text] [Related]
17. New Horizons for Precision Medicine in Biliary Tract Cancers.
Valle JW; Lamarca A; Goyal L; Barriuso J; Zhu AX
Cancer Discov; 2017 Sep; 7(9):943-962. PubMed ID: 28818953
[TBL] [Abstract][Full Text] [Related]
18. A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada.
Ramjeesingh R; Chaudhury P; Tam VC; Roberge D; Lim HJ; Knox JJ; Asselah J; Doucette S; Chhiber N; Goodwin R
Curr Oncol; 2023 Jul; 30(8):7132-7150. PubMed ID: 37622998
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100334. PubMed ID: 33592563
[TBL] [Abstract][Full Text] [Related]
20. Emerging treatment strategies in hepatobiliary cancer.
Guven DC; Yildirim HC; Chalabiyev E; Kus F; Yilmaz F; Yasar S; Akyildiz A; Aktas BY; Yalcin S; Dizdar O
Expert Rev Anticancer Ther; 2023 Mar; 23(3):243-256. PubMed ID: 36803258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
